Nielsen H, Mueller T C, Sørensen M. "一种的合成方法" [P]. European Patent, EP 3782285 A1, 2015-12-15.
Mueller T, Yamamoto T, Williams B T. "Method for the Synthesis of Ethyl 3-(3-(thiophen-2-yl)-1,2,4-oxadiazol-5-yl)benzoate" [P]. US Patent, US 10036266 B2, 2017-03-23.
发明人张德明,韩伟,杨光. "A Process for Preparing High-Purity Ethyl 3-(3-(thiophen-2-yl)-1,2,4-oxadiazol-5-yl)benzoate" [P]. 中国发明专利, 专利号 CN 112580522 B, 授权公告日 2018-10-01.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chemosphere, 2023, 2001, (11), 4946-4952.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2014, 100, (7), 8882-8892.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Ethyl 3-(3-(thiophen-2-yl)-1,2,4-oxadiazol-5-yl)benzoate Using HRMS and NMR". J. Pharm. Biomed. Anal., 2015, 1856, (5), 918-941.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2011, 2447, (6), 6802-6807.